Bausch Health Companies (BHC) Peer Comparison
$6.07
As on 10-Sep-2026 16:00EDT
Market cap
$2,453 Mln
Revenue (TTM)
$10,853 Mln
P/E Ratio
--
P/B Ratio
18.8
Div. Yield
0 %
| Bausch Health Companies (BHC) | Cronos Group Inc. Common Share (CRON) | Arbutus Biopharma Corp (ABUS) | Sundial Growers - ADR | Canopy Growth Corp (CGC) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
2,453 | 1,201 | 1,020 | 357 | 463 |
Revenue ($ Mln) |
10,853 | 243 | 182 | 928 | 321 |
Net Profit ($ Mln) |
-1,098.00 | 69.79 | 153.05 | -21.69 | -259.27 |
Net Margin (%) |
-10.12 | 28.74 | 84.23 | -2.34 | -80.67 |
RoE (%) |
-- | 5.60 | 91.29 | -2.00 | -29.99 |
Price to Earnings |
-- | 17.16 | 6.52 | -- | -- |
Price-To-Book |
18.78 | 1.12 | 3.92 | 0.46 | 0.89 |
Cashflow ($ Mln)
| Bausch Health Companies (BHC) | Cronos Group Inc. Common Share (CRON) | Arbutus Biopharma Corp (ABUS) | Sundial Growers - ADR | Canopy Growth Corp (CGC) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
1,400.00 | 26.32 | -39.64 | 70.92 | -165.75 |
|
Cash Flow from Investing Activities
|
-595.00 | -77.90 | 15.58 | 17.45 | -47.79 |
|
Cash from Financing Activities
|
-742.00 | -20.25 | 5.72 | -54.49 | 148.66 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Bausch Health Companies (BHC) | Cronos Group Inc. Common Share (CRON) | Arbutus Biopharma Corp (ABUS) | Sundial Growers - ADR | Canopy Growth Corp (CGC) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
0.76 | -0.89 | -36.37 | -1.23 | -59.69 |
|
ROE (%)
|
-17.14 | 5.60 | 91.29 | -2.00 | -29.99 |
|
ROA (%)
|
-3.57 | 5.70 | 79.37 | -1.58 | -22.80 |
|
EBIT Margin (%)
|
8.06 | 10.39 | 84.27 | -2.03 | -71.05 |
|
Net Margin (%)
|
-10.12 | 28.74 | 84.23 | -2.34 | -80.67 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Bausch Health Companies (BHC) | Cronos Group Inc. Common Share (CRON) | Arbutus Biopharma Corp (ABUS) | Sundial Growers - ADR | Canopy Growth Corp (CGC) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
10.09 | 86.39 | 1,078.78 | -1.68 | 16.90 |
|
EBIT Growth (%)
|
-56.81 | 162.49 | 367.23 | 80.39 | 49.49 |
|
Net Profit Growth (%)
|
-1,220.41 | 277.46 | 382.12 | 77.94 | 49.41 |
|
EPS Growth (%)
|
-1,242.86 | 281.14 | 374.07 | 77.34 | 85.64 |
|
Book Value Growth (%)
|
-128.74 | -1.26 | 203.81 | 0.26 | -37.19 |
Valuation Ratios
| Bausch Health Companies (BHC) | Cronos Group Inc. Common Share (CRON) | Arbutus Biopharma Corp (ABUS) | Sundial Growers - ADR | Canopy Growth Corp (CGC) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
16.40 | -105.42 | -27.51 | -27.71 | -0.16 |
|
Price / Book Value
|
-4.66 | 0.93 | 12.04 | 0.40 | 0.20 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
7.07 | -54.50 | -25.25 | 6.96 | -0.66 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Bausch Health Companies (BHC) | Cronos Group Inc. Common Share (CRON) | Arbutus Biopharma Corp (ABUS) | Sundial Growers - ADR | Canopy Growth Corp (CGC) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
-11.22 | 0.00 | 0.00 | 0.00 | 0.31 |
|
Short term debt to equity ratio
|
-0.50 | 0.00 | 0.00 | 0.03 | 0.06 |
|
Current Ratio
|
1.44 | 16.18 | 81.42 | 4.76 | 3.04 |
|
Quick Ratio
|
1.08 | 15.25 | 81.42 | 3.11 | 2.39 |
|
Interest Coverage
|
0.54 | -- | 2,014.87 | -3.13 | -4.92 |
Operating Efficiency Ratios
| Bausch Health Companies (BHC) | Cronos Group Inc. Common Share (CRON) | Arbutus Biopharma Corp (ABUS) | Sundial Growers - ADR | Canopy Growth Corp (CGC) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
20.85 | 21.45 | 98.91 | 3.55 | 13.25 |
|
Asset Turnover
|
0.35 | 0.20 | 0.94 | 0.68 | 0.28 |
|
Receivable days
|
79.82 | 106.48 | 53.89 | 11.30 | 71.03 |
|
Inventory Days
|
195.23 | 166.85 | -- | 68.84 | 167.38 |
|
Payable days
|
76.06 | 59.75 | 1,755.31 | 14.63 | 52.79 |
|
Cash Conversion Cycle
|
198.99 | 213.59 | -- | 65.51 | 185.62 |